Apellis Pharmaceuticals Inc (APLS)
42.00
+0.08
(+0.19%)
USD |
NASDAQ |
May 16, 16:00
41.97
-0.03
(-0.07%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Return Price: 42.00 for May 16, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 16, 2024 | 42.00 |
| May 15, 2024 | 41.92 |
| May 14, 2024 | 41.20 |
| May 13, 2024 | 43.01 |
| May 10, 2024 | 41.99 |
| May 09, 2024 | 42.52 |
| May 08, 2024 | 42.30 |
| May 07, 2024 | 43.90 |
| May 06, 2024 | 48.81 |
| May 03, 2024 | 47.46 |
| May 02, 2024 | 47.49 |
| May 01, 2024 | 46.05 |
| April 30, 2024 | 44.19 |
| April 29, 2024 | 47.84 |
| April 26, 2024 | 49.86 |
| April 25, 2024 | 47.93 |
| April 24, 2024 | 49.93 |
| April 23, 2024 | 48.72 |
| April 22, 2024 | 47.64 |
| April 19, 2024 | 47.53 |
| April 18, 2024 | 47.51 |
| April 17, 2024 | 48.03 |
| April 16, 2024 | 51.82 |
| April 15, 2024 | 51.50 |
| April 12, 2024 | 51.79 |
| Date | Value |
|---|---|
| April 11, 2024 | 55.73 |
| April 10, 2024 | 56.84 |
| April 09, 2024 | 55.12 |
| April 08, 2024 | 53.81 |
| April 05, 2024 | 55.91 |
| April 04, 2024 | 56.05 |
| April 03, 2024 | 56.95 |
| April 02, 2024 | 55.70 |
| April 01, 2024 | 59.71 |
| March 28, 2024 | 58.78 |
| March 27, 2024 | 58.49 |
| March 26, 2024 | 59.00 |
| March 25, 2024 | 55.53 |
| March 22, 2024 | 55.39 |
| March 21, 2024 | 56.61 |
| March 20, 2024 | 55.52 |
| March 19, 2024 | 56.92 |
| March 18, 2024 | 56.26 |
| March 15, 2024 | 56.74 |
| March 14, 2024 | 56.48 |
| March 13, 2024 | 57.36 |
| March 12, 2024 | 58.50 |
| March 11, 2024 | 60.69 |
| March 08, 2024 | 61.63 |
| March 07, 2024 | 62.44 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
17.91
Minimum
Mar 17 2020
93.31
Maximum
Jun 13 2023
46.40
Average
45.16
Median
Apr 26 2021
Total Return Price Benchmarks
| Blueprint Medicines Corp | 106.67 |
| Sarepta Therapeutics Inc | 132.67 |
| Inspire Medical Systems Inc | 159.03 |
| Alnylam Pharmaceuticals Inc | 151.38 |
| Biomarin Pharmaceutical Inc | 76.97 |